Browsing by Author "Daloglu, Hayriye"
Now showing items 1-9 of 9
-
Epstein‑Barr virus‑related lymphoproliferative disorders in T‑cell repleted haploidentical transplantation with post‑transplant cyclophosphamide
Uygun, Vedat; Ozsan, Nazan; Daloglu, Hayriye; Ozturkmen, Seda; Yalcin, Koray; Karasu, Gulsun; Yesilipek, Akif (Springer Link, 2021)EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with ... -
Hematopoetic stem cell transplantation in CD40 ligand deficiency
Uygun, Vedat; Uygun, Dilara Fatma Kocacik; Daloglu, Hayriye; Ozturkmen, Seda; Kilic, Suar Caki; Bingol, Aysen; Yalcin, Koray; Celen, Safiye Suna; Hazar, Volkan; Tezcan Karasu, Gulsun; Yesilipek, Akif (SPRINGERNATURE, 2020)[No Abstract] -
Hematopoietic stem cell transplantation in CD40 ligand deficiency: a single-center experience
Uygun, Dilara Fatma Kocacik; Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda Irmak; Celmeli, Fatih; Torun, Selda Hancerli; Ozen, Ahmet; Baris, Safa; Aydiner, Elif Karakoc; Yalcin, Koray; Kilic, Suar Caki; Hazar, Volkan; Bingol, Aysen; Yesilipek, Akif (Wiley, 2020)Deficiency of the CD40L, expressed on the surface of T lymphocytes, is caused by mutations in the glycoproteinCD40L (CD154)gene. Resulting defective humoral and cellular responses cause a clinical presentation that includes ... -
Hematopoietic stem cell transplantation in serine/threonine kinase 4 (stk4) deficiency: report of two cases and literature review
Uygun, Vedat; Keles, Sevgi; Daloglu, Hayriye; Ozturkmen, Seda; Yalcin, Koray; Karasu, Gulsun; Yesilipek, Akif (WILEY, 2022)Background Serine/threonine kinase 4 (STK4) deficiency is a combined immunodeficiency (CID) characterized by early onset recurrent bacterial, viral, and fungal infections. Allogeneic hematopoietic stem cell transplantation ... -
Pearson syndrome in a child transplanted for diamond-blackfan anemia
Uygun, Vedat; Daloglu, Hayriye; Ozturkmen, Seda; Karasu, Gulsun; Yesilipek, Akif (Sociedad Argentina de Pediatria, 2021)Pearson syndrome (PS), shares a number of overlapping features with Diamond-Blackfan anemia (DBA), including early onset of severe anemia, making differential diagnosis important. Differential diagnosis of DBA and PS is ... -
Pearson syndrome in a patient transplanted for diamond-blackfan anemia
Tezcan Karasu, Gulsun; Uygun, Vedat; Daloglu, Hayriye; Ozturkmen, Seda; Yesilipek, Akif (SPRINGERNATURE, 2020)[No Abstract] -
Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: a single-center experience
Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda; Kilic, Suar Caki; Yalcin, Koray; Celen, Safiye Suna; Hazar, Volkan; Yesilipek, Akif (Wiley, 2020)Background Despite the increasing performance of allogeneic hematopoietic cell transplantation over the last decades, graft-versus-host disease (GVHD) remains the main cause of morbidity and mortality. The efficacy of ... -
Timing of initiation of calcineurin inhibitors in pediatric haploidentical transplantation with post-transplantation cyclophosphamide: Effects on survival, relapse, and cytokine release syndrome
Uygun, Vedat; Karasu, Gulsum; Yalcin, Koray; Ozturkman, Seda; Daloglu, Hayriye; Celen, Safiye Suna; Hazar, Volkan; Yesilipek, Akif (Karger, 2022)Background: The use of unmanipulated haploidentical hematopoietic stem cell transplantations (haplo-HSCT) with post-transplant cyclophosphamide (PTCY) in children has emerged as an acceptable alternative to the patients ... -
Use of low cell dose for unmanipulated donor lymphocyte for management of cytomegalovirus infection: a single-center experience
Uygun, Vedat; Tezcan Karasu, Gulsun; Daloglu, Hayriye; Ozturkmen, Seda; Yalcın, Koray; Celen, Safiye Suna; Yesilipek, Akif (2020)Although advancements have been made in monitoring and preventing viral infections in HSCT patients, CMV reactivation still remains a critical post-transplant complication. Adoptive cell therapy is an alternative to ...
